¿Qué es Tremfya?

Tremfya (guselkumab) es un medicamento con receta fabricado por Janssen Biotech, Inc. Es un anticuerpo monoclonal humano diseñado para bloquear selectivamente la proteína interleucina-23 (IL-23), la cual desempeña un papel clave en el manejo de los procesos inflamatorios asociados con ciertas enfermedades autoinmunes. Tremfya está aprobado para el tratamiento de adultos con psoriasis en placas de moderada a grave y artritis psoriásica activa.

Side Effects

• Diarrhea, nausea, loss of appetite, stomach pain
• Fever, chills, cough, sore throat, stuffy or runny nose, body aches
• Painful cold sores or blisters on lips, nose, eyes, or genitals

Warnings

• You will need to have a skin test for tuberculosis (TB) before you start this medicine. Tell your doctor if you or anyone in your home has ever had a positive TB skin test or has been exposed to TB.
• Tell your doctor if you are pregnant or breastfeeding, or if you have liver disease, an infection, active tuberculosis (TB), or a history of TB or any infection.
• Keep all medicine out of the reach of children. Never share your medicine with anyone.
• Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.
• This medicine may also cause you to get infections more easily. Tell your doctor if you have any type or history of infection before you start treatment.